On January 2nd, 2018, the Ministry of Health of Ukraine publiched a new Register of Maximum Wholesale Prices for Medicines to Participate in the Government Program "Available Medicines", which is approved by Order of the Ministry of Health of Ukraine No. 2 dated January 2nd, 2018.
The new register "Available Medicines" contains 23 INNs. On December 27th, 2014, the Government approved changes to the program and supplemented the "Available Medications" with two other active substances for the treatment of cardiovascular diseases and type 2 diabetes - Losartan and Glibenclamide.
From 02.01.2018 to 11.01.2018 (inclusive), the Ministry of Health starts accepting applications from manufacturers / importers of medicines in the form placed on the website of the Ministry of Health for the formation of the Register of Medicinal Products subject to Reimbursement.
The Register of Medicinal Products subject to Reimbursement will be fully updated, therefore the active participants of the program must re-apply for the inclusion of drugs in the Register.
Please note that according to the information published on the website of the Ministry of Health, the approval of the updated version of the Register of Medicinal Products subject to Reimbursement, and its publication on the website of the Ministry of Health of Ukraine, by the order of the Ministry, is scheduled for January 22nd, 2018.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
